 | • レポートコード：MRC309Z7741 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の脊柱刺激（SCS）システムの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の脊柱刺激（SCS）システム市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 脊柱刺激（SCS）システムの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 脊柱刺激（SCS）システム市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・充電式、バッテリー式 用途別セグメント ・地域疼痛症候群、腰椎不全症候群、手足の神経障害性疼痛、その他 主要な市場プレーヤー ・Abbott、Boston Scientific Corporation、Medtronic、Nevro、Johns Hopkins Medicine、Axonics Modulation Technologies、ReShape Lifesciences Inc、Cyberonics、SceneRay、RISHNA 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、脊柱刺激（SCS）システム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な脊柱刺激（SCS）システムメーカーの企業概要、2019年～2022年までの脊柱刺激（SCS）システムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な脊柱刺激（SCS）システムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別脊柱刺激（SCS）システムの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの脊柱刺激（SCS）システムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での脊柱刺激（SCS）システム市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および脊柱刺激（SCS）システムの産業チェーンを掲載しています。 ・第14、15章では、脊柱刺激（SCS）システムの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 脊柱刺激（SCS）システムの概要 - 種類別分析（2018年vs2022年vs2029年）：充電式、バッテリー式 - 用途別分析（2018年vs2022年vs2029年）：地域疼痛症候群、腰椎不全症候群、手足の神経障害性疼痛、その他 - 世界の脊柱刺激（SCS）システム市場規模・予測 - 世界の脊柱刺激（SCS）システム生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Abbott、Boston Scientific Corporation、Medtronic、Nevro、Johns Hopkins Medicine、Axonics Modulation Technologies、ReShape Lifesciences Inc、Cyberonics、SceneRay、RISHNA ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：充電式、バッテリー式 ・用途別分析2018年-2029年：地域疼痛症候群、腰椎不全症候群、手足の神経障害性疼痛、その他 ・脊柱刺激（SCS）システムの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・脊柱刺激（SCS）システムのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・脊柱刺激（SCS）システムのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・脊柱刺激（SCS）システムの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・脊柱刺激（SCS）システムの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Spinal Column Stimulation (SCS) Systems market size was valued at USD 2160.8 million in 2022 and is forecast to a readjusted size of USD 3644 million by 2029 with a CAGR of 7.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain (without prior surgery and not a candidate for back surgery), and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation A spinal cord stimulator (SCS) is a small device, similar to a pacemaker, that uses electrical impulses to relieve chronic pain of the back, arms, and legs. The device masks pain signals before they reach the brain. Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain, and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation (SCS) Systems is designed to deliver low-intensity electrical impulses to nerve structures. The system is intended to be used with leads and associated extensions that are compatible with the system. SCS systems have a small implanted pulse generator, called a stimulator, and thin wires called leads. These are implanted into your body. The stimulator delivers tiny pulses of mild electric current through the leads to specific nerves on the spinal cord. These impulses mask pain signals traveling to the brain. There are a few types of SCS implants, but each is comprised of three main parts: A battery-powered pulse generator which creates the electrical charge. A lead wire with several electrodes which deliver an electrical charge to the spinal cord. A hand-held remote to power the device on and off and to adjust the settings.
This report is a detailed and comprehensive analysis for global Spinal Column Stimulation (SCS) Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Spinal Column Stimulation (SCS) Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Column Stimulation (SCS) Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Column Stimulation (SCS) Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Column Stimulation (SCS) Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spinal Column Stimulation (SCS) Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Spinal Column Stimulation (SCS) Systems market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific Corporation, Medtronic, Nevro and Johns Hopkins Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Spinal Column Stimulation (SCS) Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rechargeable
Battery-Operated
Market segment by Application
Regional Pain Syndromes
Lumbar Spine Failure Syndrome
Neuropathic Pain in Limbs
Other
Major players covered
Abbott
Boston Scientific Corporation
Medtronic
Nevro
Johns Hopkins Medicine
Axonics Modulation Technologies
ReShape Lifesciences Inc
Cyberonics
SceneRay
RISHNA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spinal Column Stimulation (SCS) Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Column Stimulation (SCS) Systems, with price, sales, revenue and global market share of Spinal Column Stimulation (SCS) Systems from 2018 to 2023.
Chapter 3, the Spinal Column Stimulation (SCS) Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Column Stimulation (SCS) Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Spinal Column Stimulation (SCS) Systems market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Column Stimulation (SCS) Systems.
Chapter 14 and 15, to describe Spinal Column Stimulation (SCS) Systems sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Spinal Column Stimulation (SCS) Systems
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Spinal Column Stimulation (SCS) Systems Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rechargeable
1.3.3 Battery-Operated
1.4 Market Analysis by Application
1.4.1 Overview: Global Spinal Column Stimulation (SCS) Systems Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Regional Pain Syndromes
1.4.3 Lumbar Spine Failure Syndrome
1.4.4 Neuropathic Pain in Limbs
1.4.5 Other
1.5 Global Spinal Column Stimulation (SCS) Systems Market Size & Forecast
1.5.1 Global Spinal Column Stimulation (SCS) Systems Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Spinal Column Stimulation (SCS) Systems Sales Quantity (2018-2029)
1.5.3 Global Spinal Column Stimulation (SCS) Systems Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Spinal Column Stimulation (SCS) Systems Product and Services
2.1.4 Abbott Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Product and Services
2.2.4 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Spinal Column Stimulation (SCS) Systems Product and Services
2.3.4 Medtronic Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Nevro
2.4.1 Nevro Details
2.4.2 Nevro Major Business
2.4.3 Nevro Spinal Column Stimulation (SCS) Systems Product and Services
2.4.4 Nevro Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nevro Recent Developments/Updates
2.5 Johns Hopkins Medicine
2.5.1 Johns Hopkins Medicine Details
2.5.2 Johns Hopkins Medicine Major Business
2.5.3 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Product and Services
2.5.4 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johns Hopkins Medicine Recent Developments/Updates
2.6 Axonics Modulation Technologies
2.6.1 Axonics Modulation Technologies Details
2.6.2 Axonics Modulation Technologies Major Business
2.6.3 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Product and Services
2.6.4 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Axonics Modulation Technologies Recent Developments/Updates
2.7 ReShape Lifesciences Inc
2.7.1 ReShape Lifesciences Inc Details
2.7.2 ReShape Lifesciences Inc Major Business
2.7.3 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Product and Services
2.7.4 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ReShape Lifesciences Inc Recent Developments/Updates
2.8 Cyberonics
2.8.1 Cyberonics Details
2.8.2 Cyberonics Major Business
2.8.3 Cyberonics Spinal Column Stimulation (SCS) Systems Product and Services
2.8.4 Cyberonics Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cyberonics Recent Developments/Updates
2.9 SceneRay
2.9.1 SceneRay Details
2.9.2 SceneRay Major Business
2.9.3 SceneRay Spinal Column Stimulation (SCS) Systems Product and Services
2.9.4 SceneRay Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 SceneRay Recent Developments/Updates
2.10 RISHNA
2.10.1 RISHNA Details
2.10.2 RISHNA Major Business
2.10.3 RISHNA Spinal Column Stimulation (SCS) Systems Product and Services
2.10.4 RISHNA Spinal Column Stimulation (SCS) Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 RISHNA Recent Developments/Updates
3 Competitive Environment: Spinal Column Stimulation (SCS) Systems by Manufacturer
3.1 Global Spinal Column Stimulation (SCS) Systems Sales Quantity by Manufacturer (2018-2023)
3.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Manufacturer (2018-2023)
3.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Spinal Column Stimulation (SCS) Systems by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Spinal Column Stimulation (SCS) Systems Manufacturer Market Share in 2022
3.4.2 Top 6 Spinal Column Stimulation (SCS) Systems Manufacturer Market Share in 2022
3.5 Spinal Column Stimulation (SCS) Systems Market: Overall Company Footprint Analysis
3.5.1 Spinal Column Stimulation (SCS) Systems Market: Region Footprint
3.5.2 Spinal Column Stimulation (SCS) Systems Market: Company Product Type Footprint
3.5.3 Spinal Column Stimulation (SCS) Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Spinal Column Stimulation (SCS) Systems Market Size by Region
4.1.1 Global Spinal Column Stimulation (SCS) Systems Sales Quantity by Region (2018-2029)
4.1.2 Global Spinal Column Stimulation (SCS) Systems Consumption Value by Region (2018-2029)
4.1.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Region (2018-2029)
4.2 North America Spinal Column Stimulation (SCS) Systems Consumption Value (2018-2029)
4.3 Europe Spinal Column Stimulation (SCS) Systems Consumption Value (2018-2029)
4.4 Asia-Pacific Spinal Column Stimulation (SCS) Systems Consumption Value (2018-2029)
4.5 South America Spinal Column Stimulation (SCS) Systems Consumption Value (2018-2029)
4.6 Middle East and Africa Spinal Column Stimulation (SCS) Systems Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
5.2 Global Spinal Column Stimulation (SCS) Systems Consumption Value by Type (2018-2029)
5.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
6.2 Global Spinal Column Stimulation (SCS) Systems Consumption Value by Application (2018-2029)
6.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Application (2018-2029)
7 North America
7.1 North America Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
7.2 North America Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
7.3 North America Spinal Column Stimulation (SCS) Systems Market Size by Country
7.3.1 North America Spinal Column Stimulation (SCS) Systems Sales Quantity by Country (2018-2029)
7.3.2 North America Spinal Column Stimulation (SCS) Systems Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
8.2 Europe Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
8.3 Europe Spinal Column Stimulation (SCS) Systems Market Size by Country
8.3.1 Europe Spinal Column Stimulation (SCS) Systems Sales Quantity by Country (2018-2029)
8.3.2 Europe Spinal Column Stimulation (SCS) Systems Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Spinal Column Stimulation (SCS) Systems Market Size by Region
9.3.1 Asia-Pacific Spinal Column Stimulation (SCS) Systems Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Spinal Column Stimulation (SCS) Systems Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
10.2 South America Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
10.3 South America Spinal Column Stimulation (SCS) Systems Market Size by Country
10.3.1 South America Spinal Column Stimulation (SCS) Systems Sales Quantity by Country (2018-2029)
10.3.2 South America Spinal Column Stimulation (SCS) Systems Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Spinal Column Stimulation (SCS) Systems Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Spinal Column Stimulation (SCS) Systems Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Spinal Column Stimulation (SCS) Systems Market Size by Country
11.3.1 Middle East & Africa Spinal Column Stimulation (SCS) Systems Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Spinal Column Stimulation (SCS) Systems Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Spinal Column Stimulation (SCS) Systems Market Drivers
12.2 Spinal Column Stimulation (SCS) Systems Market Restraints
12.3 Spinal Column Stimulation (SCS) Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Spinal Column Stimulation (SCS) Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Spinal Column Stimulation (SCS) Systems
13.3 Spinal Column Stimulation (SCS) Systems Production Process
13.4 Spinal Column Stimulation (SCS) Systems Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Spinal Column Stimulation (SCS) Systems Typical Distributors
14.3 Spinal Column Stimulation (SCS) Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer